AI assistant
CENTENE CORP — Director's Dealing 2022
Dec 14, 2022
30343_dirs_2022-12-13_d10d6bdf-62be-45b7-bdde-22eec6f8d84a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CENTENE CORP (CNC)
CIK: 0001071739
Period of Report: 2022-12-09
Reporting Person: FASOLA KENNETH J (EVP, Health Care Enterprises)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-12-09 | Phantom Stock | $0.0 | A | 44.096 | Acquired | 2022-12-09 | Common Stock (44.096) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 182536 | Direct |
Footnotes
F1: Ownership includes 161,543 shares of restricted stock subject to vesting requirements.
F2: Each share of phantom stock represents the right to receive the fair market value of one share of Centene common stock.
F3: The phantom stock was acquired by Mr. Fasola through regularly scheduled payroll contributions to the Company's deferred compensation plan.
F4: The phantom stock has no formal expiration date. The phantom stock will be settled in cash or other non-Company securities upon Mr. Fasola's termination with the Company, or on such other date Mr. Fasola may elect.